Journal of Pharma and Drug Innovation

Now Accepting Manuscripts Annual (One issue per year) Open Access Single-Blind Peer Review
Editorial & Review Timeline
3 - 4 Days Initial Quality Review
20 Days Peer Evaluation Summary
30 - 45 Days Complete Editorial Processing Time

Editorial Board

The Editorial Board of the journal is responsible for maintaining the quality and integrity of the journal's content. The board members are experts in their respective fields and play a crucial role in the peer review process, ensuring that all articles published meet the highest academic standards.

The Editorial Board is committed to upholding the principles of academic excellence, transparency, and ethical publishing practices. They work closely with authors, reviewers, and the editorial team to facilitate a smooth publication process.

Editor-in-Chief

Leonard-Ionut Atanase (Ph.D)

Editor-in-Chief View Profile

  Full Professor Former Dean

  Faculty of Medical Dentistry

  Apollonia University of Iasi

  Romania

Prof. Dr. Leonard-Ionut Atanase is a leading polymer scientist specializing in drug delivery systems, polymeric micelles, hydrogels, nanocapsules, and biomaterials for biomedical applications.

He received his PhD in France and has extensive postdoctoral and academic experience in European research institutions. He has published over 100 ISI-indexed papers, contributed to internationally recognized book chapters, and has an H-index of 30.

He has coordinated and collaborated on more than 12 research projects and participated in over 300 scientific events. Since 2022, he is listed in the Top 2% Most Influential Scientists by Stanford University.

His work drives innovation in controlled drug release, tissue regeneration, and polymer therapeutics.

Editorial Members

Dr Mouhaned Y Al-Darwesh (Ph.D)

Editor-Member View Profile

  Assistant Lecturer

  Department of Chemistry

  University of Anbar

  Iraq

Dr. Mouhaned Youif Turkey Al-Darwesh is an academic and researcher in Chemistry, Pharmaceutical and Medical Sciences at the University of Anbar, Iraq. He holds a Ph.D. from the University of Tunis El Manar, Tunisia, along with B.Sc. and M.Sc. degrees from the University of Anbar. His research focuses on pharmaceutical nanotechnology, drug loading and delivery systems, nanocarriers, drug solubility, stability, bioavailability, targeted and controlled drug delivery, and the characterization of drug-loading and release properties. He is also actively involved in clinical and laboratory research and has extensive peer-review experience, having reviewed approximately 100 scientific manuscripts for international journals.

Prof Hani A Alhadrami

Prof Hani A Alhadrami (Ph.D)

Editor-Member View Profile

  Professor Consultant of Molecular Diagnostics and Medical Biotechnology

  Medical Biotechnology

  King Abdulaziz University (KAU)

  Saudi Arabia

Prof. Hani A. Alhadrami is a Professor and Consultant of Molecular Diagnostics and Medical Biotechnology at the Faculty of Applied Medical Sciences, King Abdulaziz University, Jeddah, Saudi Arabia. He also serves as Head of the Nanobiotechnology for Medical Applications Research Group at the King Fahd Medical Research Center and Consultant Scientist at the Special Infectious Agents Unit (BSL-3) at KAU Hospital. He obtained his PhD in Medical Biotechnology from the University of Aberdeen (UK), an MSc in Microbiology and Biotechnology with Commendation, and a Diploma in Medical Education from KAU. Prof. Alhadrami is an inventor of multiple U.S. patents and has published over 100 peer-reviewed articles. His work focuses on molecular diagnostics, biosensing technologies, nanomedicine, and infectious disease diagnostics.

Prof Josiana Adelaide Vaz (Ph.D)

Editor-Member View Profile

  Department of Diagnostic and Therapeutic Technologies

  Instituto Politécnico de Bragança

  Portugal

Dr. Josiana Adelaide Vaz is an Adjunct Professor at the Polytechnic Institute of Bragança and a Researcher at the LiveWell Centre for Active Living and Wellbeing. She holds a PhD in Pharmaceutical Sciences from the University of Porto. Her multidisciplinary career covers biomedical laboratory sciences, pharmacology, natural products and medical biotechnology. Her main research focuses on bioactive compounds from wild mushrooms and plants, antioxidant and antiproliferative activity, biomonitoring of environmental and occupational exposure, sericin-based biomaterials and sleep-related health determinants. She has authored over 50 scientific works, collaborated with more than 100 researchers and participates in several funded projects including IberLongeva, NSL – New Long-lived Societies, Bio4Drinks and Acorn4Med. She also holds multiple academic governance roles.

Prof Hamdy Abdelkader (Ph.D)

Editor-Member View Profile

  Faculty of Pharmacy

  Faculty of Pharmacy, Minia University

  King Khalid University

  Egypt

Prof. Hamdy Abdelkader is a Professor in Pharmaceutics at the College of Pharmacy, King Khalid University, KSA. He is a Fellow of the Higher Education Academy (UK). His academic career spans Africa, Asia, Oceania, and Europe. He received his BPharm from Alexandria University (2000) and PhD from the University of Auckland, New Zealand (2011). He was awarded the prestigious Leverhulme Fellowship in the UK (2013–2015). His research focuses on ocular drug delivery and age-related eye diseases. He has served as Associate Editor-in-Chief for JABPS and is on editorial boards of multiple journals. He has lectured internationally, including in Egypt and the UK.

Dr Aura Rusu (Ph.D)

Editor-Member View Profile

  Professor

  Faculty of Pharmacy

  University of Medicine, Pharmacy, Science and Technology of Targu Mures

  Romania

Prof. Aura Rusu is a Full Professor at the Faculty of Pharmacy, George Emil Palade University of Medicine, Pharmacy, Science and Technology of Târgu Mureș, Romania. Her academic journey spans more than two decades, with advanced qualifications in Pharmacy, Quality Management, and Drug Design. She coordinates courses in Pharmaceutical and Therapeutic Chemistry, Medicinal Chemistry, and Drug Design.
Her research interests focus on pharmaceutical and medicinal chemistry, antibacterial agents, metal complexes, analytical chemistry, and drug design.
She has authored 14 books and over 80 peer-reviewed papers (Impact Factor: 142.69, H-index: 18), serves as a reviewer for more than 30 international journals, and has been Guest Editor for MDPI journals such as Pharmaceutics, Molecules, and Cosmetics.